Integration of palliative and supportive care in the management of advanced liver disease: development and evaluation of a prognostic screening tool and supportive care intervention

Background and objectives Patients with decompensated cirrhosis rarely receive palliative and supportive care interventions, which are routine in other life-limiting diseases. We aimed to design and evaluate a prognostic screening tool to routinely identify inpatients with decompensated cirrhosis at high risk of dying over the coming year, alongside the development of a supportive care intervention. Design Clinical notes from consecutive patients admitted as an emergency to University Hospitals Bristol with a diagnosis of cirrhosis over two distinct 90-day periods were scrutinised retrospectively for the presence or absence of five evidence-based factors associated with poor prognosis. These were analysed against their ability to predict mortality at 1 year. ‘Plan-Do-Study-Act’ (PDSA) methodology was used to incorporate poor-prognosis screening into the routine assessment of patients admitted with cirrhosis, and develop a supportive care intervention. Results 73 admissions were scrutinised (79.5% male, 63% alcohol-related liver disease, median age 54). The presence of three or more poor-prognosis criteria at admission predicted 1-year mortality with sensitivity, specificity and positive predictive value of 72.2%, 83.8% and 81.3%, respectively, and was used as a trigger for implementing the supportive care intervention. Following modification from six PDSA cycles, prognostic screening was integrated into the assessment of all patients admitted with decompensated cirrhosis, with the supportive care intervention (developed simultaneously) instigated for appropriate patients. Conclusions We describe a model of care which identifies inpatients with cirrhosis at significant risk of dying over the coming year, and describe development of a supportive care intervention, which can be offered to suitable patients in parallel to ongoing active management.

[1]  P. Dimitrijevic National End of Life Care Intelligence Network , 2016 .

[2]  Christopher T. Chan,et al.  How to Measure and Interpret Quality Improvement Data. , 2016, Clinical journal of the American Society of Nephrology : CJASN.

[3]  V. Navarro,et al.  Benefit of Early Palliative Care Intervention in End-Stage Liver Disease Patients Awaiting Liver Transplantation. , 2015, Journal of pain and symptom management.

[4]  A. Marshall,et al.  Palliative care for cirrhosis: a UK survey of health professionals’ perceptions, current practice and future needs , 2015, Frontline Gastroenterology.

[5]  A. Marshall,et al.  ECONOMIC ANALYSIS OF COSTS FOR PATIENTS WITH END STAGE LIVER DISEASE OVER THE LAST YEAR OF LIFE , 2015, BMJ Supportive & Palliative Care.

[6]  M. Bellis,et al.  Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis , 2014, The Lancet.

[7]  M. Buss,et al.  Integration of palliative care in end-stage liver disease and liver transplantation. , 2014, Journal of palliative medicine.

[8]  J. Newton,et al.  Health related quality of life in people with advanced chronic liver disease. , 2014, Journal of hepatology.

[9]  S. Murray,et al.  OC-034 Outcome Of Patients Considered Unsuitable For Liver Transplantation – A Missed Opportunity For Palliative Care? , 2014, Gut.

[10]  E. Kendrick,et al.  Getting it right: improving end of life care for people living with liver disease , 2013 .

[11]  S. Ryder,et al.  OP01 Who dies from alcoholic liver disease and where are possible therapeutic interventions missed? An analysis of 755 deaths in a health community 2007–2010 , 2011, Gut.

[12]  R. Chapman,et al.  OP01 WHO DIES FROM ALCOHOLIC LIVER DISEASE AND WHERE ARE POSSIBLE THERAPEUTIC INTERVENTIONS MISSED? AN ANALYSIS OF 755 DEATHS IN A HEALTH COMMUNITY , 2011 .

[13]  ChiMat,et al.  NHS Atlas of Variation in Healthcare , 2008 .

[14]  J. Talwalkar,et al.  Palliative care for patients with end-stage liver disease ineligible for liver transplantation. , 2006, Gastroenterology clinics of North America.

[15]  N. Dawson,et al.  Dying with End Stage Liver Disease with Cirrhosis: Insights from SUPPORT , 2000, Journal of the American Geriatrics Society.